http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-293819-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_628db03ba4f8948ecd211fb3d46b9ef4 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-08 |
| filingDate | 1995-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1996-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fc188bd30d7b86d4541411530cd6988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_193574cc4da4da33ee5f6dd1dd495bb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_674ed7abc0e251be7c5f13589301f7d0 |
| publicationDate | 1996-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-293819-B |
| titleOfInvention | Antiplatelet coumarin derivatives |
| abstract | The novel compounds of formula I and II provided in this invention are the two types of derivatives, which was preperated from (alpha)-methylene-(gamma)-butyrolactones and coumarin. In view that these compounds are found to be potent inhibitors of platelet aggregation. Compounds of formula I and II in which R1, R2, R3 represents H, C 1-6 alkyl, in which R represents C1-6 alkyl, benzene, group which is optionally substituted by one or more R4, R5, R6. In which R4, R5, R6 represents C1-6 alkyl, C1-7 alkoxyl, halogens. |
| priorityDate | 1995-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 99.